LifeStance Health PE Ratio 2020-2023 | LFST
Current and historical p/e ratio for LifeStance Health (LFST) from 2020 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. LifeStance Health PE ratio as of April 26, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
LifeStance Health PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-04-26 | 6.20 | 0.00 | |
2023-12-31 | 7.83 | $-0.51 | 0.00 |
2023-09-30 | 6.87 | $-0.52 | 0.00 |
2023-06-30 | 9.13 | $-0.46 | 0.00 |
2023-03-31 | 7.43 | $-0.52 | 0.00 |
2022-12-31 | 4.94 | $-0.61 | 0.00 |
2022-09-30 | 6.62 | $-0.80 | 0.00 |
2022-06-30 | 5.56 | $-1.04 | 0.00 |
2022-03-31 | 10.11 | $-1.07 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical - Outpatient & Home Care | $2.370B | $1.056B |
LifeStance Health Group Inc. is provider of virtual and in-person outpatient mental health care for children, adolescents and adults of mental health conditions. LifeStance Health Group Inc. is based in SCOTTSDALE, Ariz. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Fresenius SE (FSNUY) | Germany | $16.392B | 9.92 |
Quest Diagnostics (DGX) | United States | $14.915B | 15.41 |
DaVita (DVA) | United States | $11.709B | 15.93 |
Chemed (CHE) | United States | $8.472B | 26.30 |
Encompass Health (EHC) | United States | $8.259B | 21.25 |
Elanco Animal Health (ELAN) | United States | $6.552B | 14.90 |
Option Care Health (OPCH) | United States | $5.147B | 19.48 |
RadNet (RDNT) | United States | $3.314B | 96.80 |
Amedisys (AMED) | United States | $2.999B | 21.25 |
Astrana Health (ASTH) | United States | $2.057B | 25.68 |
Addus HomeCare (ADUS) | United States | $1.548B | 23.52 |
U.S Physical Therapy (USPH) | United States | $1.516B | 39.30 |
Pennant (PNTG) | United States | $0.624B | 36.46 |
Aveanna Healthcare Holdings (AVAH) | United States | $0.423B | 0.00 |
Atai Life Sciences (ATAI) | Germany | $0.323B | 0.00 |
Daxor (DXR) | United States | $0.046B | 0.00 |
MEDIROM Healthcare Technologies (MRM) | Japan | $0.029B | 0.00 |
ATI Physical Therapy (ATIP) | United States | $0.018B | 0.00 |
Psychemedics (PMD) | United States | $0.015B | 0.00 |
Ontrak (OTRK) | United States | $0.014B | 0.00 |
Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
IMAC Holdings (BACK) | United States | $0.005B | 0.00 |